Latest News

Patients with polyendocrine metabolic ovarian syndrome have higher ocular disease prevalence.

How this gene-agnostic optogenetic approach could fill a critical gap for advanced inherited retinal degeneration.

Length and width, not thickness, emerge as key drivers of higher-order aberrations.

Border zone lifetime gradient correlated with growth rate over 5 years

Real-world data support EndoArt as donor-independent option in high-risk patients

Offline smartphone AI fundus screening detects diabetic retinopathy, glaucoma, and macular degeneration in one capture, delivering high accuracy for low-resource eye care.

Varicella vaccine drove the largest risk reduction in a 5-vaccine, multi-million-patient analysis

Biologic therapies linked to high remission rates over 2-year follow-up

In this Q&A, Dipanjan Pan, PhD, breaks down the science behind the COSMIC tear biosensor platform and what it will take to bring it to clinical use.

Researchers identify microbial shifts tied to corneal disease history

Deeper anterior chamber depth and shorter disease course predicted better surgical outcomes

Sura-vec is a 1-time investigational gene therapy designed to deliver sustained treatment in wet AMD, diabetic retinopathy and other chronic retinal conditions.

The FDA has granted priority review to satralizumab for thyroid eye disease, with a PDUFA date of October 15, 2026, based on phase 3 SatraGO trial data.